Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients

Area of Science:

• Neurology
• Infectious Diseases
• Critical Care Medicine

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, presents with diverse clinical manifestations.
• Prothrombotic complications are a concern in severe COVID-19 cases, leading to expert recommendations for anticoagulation.
• Optimal anticoagulation strategies and their safety profiles in COVID-19 patients require further investigation.

Observation:

• This report details three critically ill patients with COVID-19 who developed intracranial hemorrhage.
• These events occurred while patients were undergoing various anticoagulation regimens.
• The clinical course of these patients was analyzed in the context of their anticoagulation therapy.

Findings:

• Intracranial hemorrhage is a potential complication in critically ill COVID-19 patients.
• The use of anticoagulation in COVID-19 patients may be associated with an increased risk of bleeding, including intracranial hemorrhage.
• The specific safety and efficacy of different anticoagulation regimens in this population remain unclear.

Implications:

• These cases highlight the critical need for careful consideration and further research into anticoagulation protocols for COVID-19 patients.
• Understanding the risks and benefits of anticoagulation is crucial for managing severe SARS-CoV-2 infections.
• Future clinical trials should focus on establishing evidence-based guidelines for anticoagulation to prevent both thrombosis and hemorrhage.